Solid Biosciences Inc. (SLDB) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Discover latest Solid Biosciences Inc. (SLDB) short-term stock forecast for year 2025, month by month, and long-term SLDB price prediction for years 2025 to 2050. Check SLDB historical stock performance, analyst ratings (Buy, Sell, or Hold), and stay updated with the latest SLDB news and headlines.
1 Month Prediction
$21.09 [282.09%]
3 Month Prediction
$15.42 [179.37%]
6 Month Prediction
$16.65 [201.58%]
1 Year Prediction
$18.54 [235.78%]
3 Year Prediction
$23.94 [333.72%]
5 Year Prediction
$29.11 [427.37%]
About Solid Biosciences Inc.
Solid Biosciences Inc. specializes in gene therapy. It develops treatments for rare neuromuscular and cardiac diseases. Solid Biosciences was founded in 2013 by individuals personally affected by Duchenne.
Their lead product candidate, SGT-003, targets Duchenne muscular dystrophy (Duchenne). Solid's other product, SGT-501, targets catecholaminergic polymorphic ventricular tachycardia (CPVT). Also, The company has collaborated with Mayo Clinic to develop gene therapies for genetic heart diseases.
The company is headquartered in Charlestown, Massachusetts, USA.
Solid Biosciences Inc. (SLDB) Historical Performance
IPO Date
Solid Biosciences Inc. (NASDAQ:SLDB) went public on 25 January, 2018.
Change
Since inception, SLDB has decreased by 98.56%. In the last 5 years, SLDB has fallen from $35.85 to $5.52, a massive -84.6% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $119.55 and a low of $2.23.
52 Week Range
$2.88
$15.05
The current price $5.52 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
SLDB Stock Price History
Based on SLDB stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the SLDB stock has fallen from $30.45 - $113.7 to $3.18 - $5.52, which is down -96.04%. Currently, the stock follows downward trend.
Here, we have calculated stock range of SLDB, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $30.45 - $113.7 | $48.06 | -56.19 | 1 Year Change |
| 2021 | $26.25 - $119.55 | $57.49 | -47.6 | 2 Year Change |
| 2022 | $5.38 - $18.3 | $9.99 | -90.89 | 3 Year Change |
| 2023 | $2.23 - $7.58 | $4.66 | -95.75 | 4 Year Change |
| 2024 | $4.0 - $13.32 | $7.7 | -92.98 | 5 Year Change |
| 2025 | $3.18 - $5.52 | $4.35 | -96.04 | 6 Year Change |
SLDB Price Performance
6-Month Performance
SLDB stock dropped by 20.80% in the last six months.
1-Year Performance
The stock has trended downwards by 58.56% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 69.33%.
5-Year Performance
In the last 5 years, the stock has gone down by 84.60%.
According to Solid Biosciences Inc.'s historical data, below graph gives us the exact picture of how the SLDB stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 2 years and a decline in 3 years.
2020
70.34% ↑
2021
76.91% ↓
2022
79.50% ↓
2023
14.13% ↑
2024
34.85% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Solid Biosciences Inc. (SLDB) Financials & Stock Analysis
Market Capitalization
Solid Biosciences Inc. has a market capitalization of $220.55M, which places SLDB in the micro-cap category.
Fundamental Analysis
EPS: $-0.79 (Q3), $-4.83 (1Y)
EPS increased 29.51% since last quarter, and decreased 52.18% since last year.
Net Income: $-32.73 M (Q3), $-96.02 M (1Y)
Net Income increased 30.52% since last quarter, and increased 11.67% since last year.
Free Cash Flow: $-23.72 M (Q3), $-95.69 M (1Y)
Free Cash Flow increased N/A since last quarter, and decreased N/A since last year.
Below, we have listed 12 key indicators for Fundamental analysis for SLDB stock. These indicators help you understand Solid Biosciences Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for SLDB stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $3.39 |
| SMA50 | $3.88 |
| SMA200 | $6.58 |
| RSI | 81.11 |
| Beta | 2.01 |
SMA20 < Current Price
This signals SLDB stock is in short-term bullish momentum.
SMA50 < Current Price
This signals SLDB stock is in mid-term bullish momentum.
SMA200 > Current Price
This signals SLDB stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for SLDB stock is Bearish. Out of all indicators, 3 indicates bullish signals, 4 signals bearish trends and 2 gives neutral trends. The SLDB stock forecast was last updated on 21 February, 2025.
Solid Biosciences Inc. (SLDB) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $15.46 by the end of 2025, and can reach around $18.43 to $21.23 in 2026. And, the long-term forecast suggests that the stock may further jump to $8.17 - $8.76 in 2028, and $23.64 - $30.72 by 2031. So, the SLDB stock shows a strong upward trend in the next several years.
Short-term SLDB Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-03 | $21.09 | 282.07% |
| 2025-04 | $16.31 | 195.47% |
| 2025-05 | $15.42 | 179.35% |
| 2025-06 | $12.78 | 131.52% |
| 2025-07 | $16.28 | 194.93% |
| 2025-08 | $16.65 | 201.63% |
| 2025-09 | $12.28 | 122.46% |
| 2025-10 | $11.58 | 109.78% |
| 2025-11 | $12.06 | 118.48% |
| 2025-12 | $15.46 | 180.07% |
In 2025, the SLDB stock price is expected to fluctuate between $11.58 and $21.09. According to the monthly forecast, the stock could rise to $15.46 by December 2024. If compared to the SLDB's current price, the stock could gain 180.07% by the end of this year.
Long-term SLDB Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $18.43 | $18.53 | $21.23 | 284.6% |
| 2027 | $31.32 | $13.08 | $19.26 | 248.91% |
| 2028 | $8.17 | $19.99 | $8.76 | 58.7% |
| 2029 | $16.46 | $33.28 | $26.07 | 372.28% |
| 2030 | $21.00 | $11.66 | $24.97 | 352.36% |
| 2031 | $23.64 | $39.60 | $30.72 | 456.52% |
| 2032 | $25.55 | $39.80 | $30.91 | 459.96% |
| 2033 | $46.35 | $22.19 | $60.04 | 987.68% |
| 2034 | $57.52 | $15.36 | $46.44 | 741.3% |
| 2035 | $24.18 | $30.24 | $48.65 | 781.34% |
| 2036 | $49.86 | $36.04 | $44.19 | 700.54% |
| 2037 | $5.56 | $48.56 | $17.32 | 213.77% |
| 2038 | $44.98 | $17.64 | $59.25 | 973.37% |
| 2039 | $28.61 | $36.37 | $47.03 | 751.99% |
| 2040 | $45.24 | $35.64 | $52.74 | 855.43% |
| 2041 | $66.04 | $56.35 | $45.74 | 728.62% |
| 2042 | $65.12 | $42.19 | $35.24 | 538.41% |
| 2043 | $44.78 | $81.93 | $1.15 | -79.17% |
| 2044 | $84.31 | $60.30 | $65.69 | 1090.04% |
| 2045 | $16.83 | $73.39 | $89.76 | 1526.09% |
| 2046 | $74.56 | $79.72 | $54.78 | 892.39% |
| 2047 | $69.42 | $94.20 | $76.20 | 1280.43% |
| 2048 | $45.91 | $61.78 | $79.89 | 1347.28% |
| 2049 | $79.91 | $54.07 | $97.77 | 1671.2% |
| 2050 | $135.55 | $79.38 | $55.24 | 900.72% |
| 2051 | $80.11 | $66.72 | $54.32 | 884.06% |
Solid Biosciences Inc. (SLDB) Stock Price Prediction & Forecast 2025
At the start of 2025, the SLDB stock was at $3.18. Today, it is trading at $5.52, which is 73.58% increase from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $15.46 by December 2025 with a 180.07% change.
Solid Biosciences Inc. (SLDB) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant appreciation in the SLDB stock. During this period, the SLDB's price is forecasted to shift from $18.43 to $24.97, which is 35.49% gain.
In 2026, the stock would possibly open at $18.43, escalates to $18.53 by mid-year, and wraps up at $21.23, reflecting a 284.68% increase from today's price. Further moving to 2030, the stock can kick off the year at $21.00, soar to $11.66 by mid-year, and finish at $24.97, which is 352.40% change from current price.
Solid Biosciences Inc. (SLDB) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $23.64 to $52.74, which is up 456.51%
In 2031, we can expect SLDB to fluctuate between $23.64 and $30.72, a shift indicating a 456.51% gain by year-end compared to current price. And Until 2040, SLDB can likely vary from $45.24 to $52.74. By the end of 2040, the stock could record a 855.51% rise from today's stock price.
Solid Biosciences Inc. (SLDB) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the SLDB stock can see an a downturn from $66.04 to $55.24 in this period. In 2041, the stock can experience a low of $56.35 by mid-year, closing the year at $45.74. This results in a 920.88% increase from today.
Moving towards the end of 2050, SLDB is projected to open the year at $135.55. The stock may dip to $79.38 during mid-year and finish the year at $55.24. Compared to the stock's current price, this translates to an overall gain of 900.66% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
SLDB Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| ADTX | Aditxt, Inc. | - | $0.07 | -34.58% ▼ | $1328.57 ▲ |
| CRSP | CRISPR Therapeutics AG | - | $49.72 | 19.55% ▲ | $90.65 ▲ |
| GALT | Galectin Therapeutics Inc. | - | $1.41 | 12.80% ▲ | $268.23 ▲ |
| MBRX | Moleculin Biotech, Inc. | - | $2.18 | 44.37% ▲ | $336.52 ▲ |
| MNMD | Mind Medicine (MindMed) Inc. | - | $9.89 | 45.66% ▲ | $96.36 ▲ |
Last updated Feb 21 at 2:33 AM
SLDB : Buy, Sell Or Hold?
Analyst Ratings
Based on 10 analysts, 4 rated as a strong buy, 6 recommended a buy, 0 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.Three months ago, out of 9 analysts, 4 analysts gave a strong buy rating, 5 a buy rating, 0 a hold rating, 0 advised selling, and 0 suggested a strong sell.So, according to analyst ratings, the recommendation for SLDB stock is Buy.
Expert Analysis
According to SLDB short-term and long-term forecast, Solid Biosciences Inc. shares are projected to go up by 900.72%, and reach a value of $55.24 per share by 2050.
As per technical analysis, indicators show a Bearish sentiment, while Fear & Greed Index stands at 42.857142857142854, which signals Fear. Also, SLDB has recorded 8/30 green days, which reflects a 40.0% positivity rate with a price volatility of 0.09%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that SLDB stock is undervalued. So, Based on SLDB prediction and analysis, it may be the best time to sell SLDB stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "SLDB” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.